
Krebs Biochemicals & Industries Ltd Locks at Upper Circuit With 20% Gain — Buyers Queue, Sellers Absent
2026-04-06 11:00:05At Rs 57.15, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Krebs Biochemicals & Industries Ltd locked at its upper circuit of 20% on 6 Apr 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Krebs Biochemicals & Industries Ltd Falls to 52-Week Low of Rs 40.92 as Sell-Off Deepens
2026-03-30 13:08:35For the third consecutive session, Krebs Biochemicals & Industries Ltd has seen its share price decline sharply, hitting a fresh 52-week low of Rs 40.92 on 30 Mar 2026. This marks an 11.6% drop over three days, underscoring persistent selling pressure amid broader market weakness.
Read full news article
Krebs Biochemicals & Industries Ltd Falls to 52-Week Low of Rs 46.54 as Sell-Off Deepens
2026-03-27 10:49:17For the second consecutive session, Krebs Biochemicals & Industries Ltd has declined further, hitting a fresh 52-week low of Rs 46.54 on 27 Mar 2026, extending its downward trajectory amid broader market weakness.
Read full news article
Krebs Biochemicals & Industries Ltd is Rated Strong Sell
2026-03-27 10:10:15Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Krebs Biochemicals & Industries Ltd Falls to 52-Week Low of Rs 46.55 as Sell-Off Deepens
2026-03-24 15:41:26For the third consecutive session, Krebs Biochemicals & Industries Ltd has closed lower, culminating in a fresh 52-week low of Rs 46.55 on 24 Mar 2026. This decline comes amid a broader market environment where the Sensex is attempting a recovery, highlighting a stark divergence in performance.
Read full news article
Krebs Biochemicals & Industries Ltd Falls to 52-Week Low of Rs 46.72 as Sell-Off Deepens
2026-03-23 15:16:22A sharp decline has pushed Krebs Biochemicals & Industries Ltd to a fresh 52-week low of Rs 46.72 on 23 Mar 2026, extending its recent downtrend amid broader market weakness and company-specific headwinds.
Read full news article
Krebs Biochemicals & Industries Ltd Falls to 52-Week Low of Rs 47 as Sell-Off Deepens
2026-03-20 11:40:07For the fifth consecutive session, Krebs Biochemicals & Industries Ltd closed lower, slipping to a fresh 52-week low of Rs 47 on 20 Mar 2026, marking a 4.45% decline intraday despite opening with a modest gain. This latest drop extends the stock’s downward trajectory amid persistent underperformance relative to its sector and the broader market.
Read full news article
Krebs Biochemicals & Industries Ltd Falls to 52-Week Low Amidst Continued Downtrend
2026-03-19 16:00:07Krebs Biochemicals & Industries Ltd has touched a new 52-week low, closing just 2.22% above its lowest price of Rs 48.1, marking a significant milestone in its ongoing decline. Despite a modest 1.23% gain over the past two days, the stock remains under pressure, trading below all key moving averages amid a challenging market environment.
Read full news article
Krebs Biochemicals & Industries Ltd Hits 52-Week Low Amidst Continued Downtrend
2026-03-17 10:50:02Krebs Biochemicals & Industries Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.48.1 today, marking a significant decline in its stock price amid broader market movements and company-specific performance factors.
Read full news articleClosure of Trading Window
19-Mar-2026 | Source : BSEThe Company has enclosinh herewith intimation for closure of trading window for considaration of audited financial results for the 4th quarter and year ended 31.03.2026.
Announcement under Regulation 30 (LODR)-Newspaper Publication
10-Feb-2026 | Source : BSEThe Company has enclosing copy of newspaper advertisement of financial results for the quarter ended 31.12.2025
Results Quarter Ended 31.12.2025
09-Feb-2026 | Source : BSEResult for the quarter ended 31.12.2025
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Krebs Biochemicals & Industries Ltd has announced 21:100 rights issue, ex-date: 31 Jan 19






